These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30838207)

  • 1. Plants Developed by New Genetic Modification Techniques-Comparison of Existing Regulatory Frameworks in the EU and Non-EU Countries.
    Eckerstorfer MF; Engelhard M; Heissenberger A; Simon S; Teichmann H
    Front Bioeng Biotechnol; 2019; 7():26. PubMed ID: 30838207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An EU Perspective on Biosafety Considerations for Plants Developed by Genome Editing and Other New Genetic Modification Techniques (nGMs).
    Eckerstorfer MF; Dolezel M; Heissenberger A; Miklau M; Reichenbecher W; Steinbrecher RA; Waßmann F
    Front Bioeng Biotechnol; 2019; 7():31. PubMed ID: 30891445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum: An EU Perspective on Biosafety Considerations for Plants Developed by Genome Editing and Other New Genetic Modification Techniques (nGMs).
    Eckerstorfer MF; Dolezel M; Heissenberger A; Miklau M; Reichenbecher W; Steinbrecher RA; Waßmann F
    Front Bioeng Biotechnol; 2019; 7():90. PubMed ID: 31119128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosafety regulatory frameworks in Kenya, Nigeria, Uganda and Sweden and their potential impact on international R&D collaborations.
    Ongu I; Olayide P; Alexandersson E; Mugwanya Zawedde B; Eriksson D
    GM Crops Food; 2023 Dec; 14(1):1-17. PubMed ID: 36987578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precise plant breeding using new genome editing techniques: opportunities, safety and regulation in the EU.
    Hartung F; Schiemann J
    Plant J; 2014 Jun; 78(5):742-52. PubMed ID: 24330272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically modified organisms: adapting regulatory frameworks for evolving genome editing technologies.
    Rozas P; Kessi-Pérez EI; Martínez C
    Biol Res; 2022 Oct; 55(1):31. PubMed ID: 36266673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EU regulatory framework on genetically modified organisms (GMOs).
    Bruetschy C
    Transgenic Res; 2019 Aug; 28(Suppl 2):169-174. PubMed ID: 31321701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roads Forward for European GMO Policy-Uncertainties in Wake of ECJ Judgment Have to be Mitigated by Regulatory Reform.
    Wasmer M
    Front Bioeng Biotechnol; 2019; 7():132. PubMed ID: 31231643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
    J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and traceability of genetically modified organisms in the food production chain.
    Miraglia M; Berdal KG; Brera C; Corbisier P; Holst-Jensen A; Kok EJ; Marvin HJ; Schimmel H; Rentsch J; van Rie JP; Zagon J
    Food Chem Toxicol; 2004 Jul; 42(7):1157-80. PubMed ID: 15123385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Call for More Effective Regulation of Clinical Trials with Advanced Therapy Medicinal Products Consisting of or Containing Genetically Modified Organisms in the European Union.
    Beattie S;
    Hum Gene Ther; 2021 Oct; 32(19-20):997-1003. PubMed ID: 33843251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic modification in Malaysia and India: current regulatory framework and the special case of non-transformative RNAi in agriculture.
    Darsan Singh JK; Mat Jalaluddin NS; Sanan-Mishra N; Harikrishna JA
    Plant Cell Rep; 2019 Dec; 38(12):1449-1463. PubMed ID: 31350570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory and Policy Considerations Around Genome Editing in Agriculture.
    Friedrichs S; Ludlow K; Kearns P
    Methods Mol Biol; 2022; 2495():327-366. PubMed ID: 35696041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory frameworks can facilitate or hinder the potential for genome editing to contribute to sustainable agricultural development.
    Mbaya H; Lillico S; Kemp S; Simm G; Raybould A
    Front Bioeng Biotechnol; 2022; 10():959236. PubMed ID: 36246373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Certain new plant breeding techniques and their marketability in the context of EU GMO legislation - recent developments.
    Zimny T; Sowa S; Tyczewska A; Twardowski T
    N Biotechnol; 2019 Jul; 51():49-56. PubMed ID: 30779963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory hurdles for genome editing: process- vs. product-based approaches in different regulatory contexts.
    Sprink T; Eriksson D; Schiemann J; Hartung F
    Plant Cell Rep; 2016 Jul; 35(7):1493-506. PubMed ID: 27142995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strengthening regulatory capacity for gene drives in Africa: leveraging NEPAD's experience in establishing regulatory systems for medicines and GM crops in Africa.
    Glover B; Akinbo O; Savadogo M; Timpo S; Lemgo G; Sinebo W; Akile S; Obukosia S; Ouedraogo J; Ndomondo-Sigonda M; Koch M; Makinde D; Ambali A
    BMC Proc; 2018; 12(Suppl 8):11. PubMed ID: 30079102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for the Assessment of Potential Environmental Effects of Genome-Editing Applications in Plants in the EU.
    Eckerstorfer MF; Dolezel M; Engelhard M; Giovannelli V; Grabowski M; Heissenberger A; Lener M; Reichenbecher W; Simon S; Staiano G; Wüst Saucy AG; Zünd J; Lüthi C
    Plants (Basel); 2023 Apr; 12(9):. PubMed ID: 37176822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New GMO regulations for old: Determining a new future for EU crop biotechnology.
    Davison J; Ammann K
    GM Crops Food; 2017 Jan; 8(1):13-34. PubMed ID: 28278120
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.